Skip to Main Content

Advertisement

Skip Nav Destination

CD4-Directed Peptide Vaccination Augments an Antitumor Response, but Efficacy Is Limited by the Number of CD8+ T Cell Precursors1

J Immunol (2004) 172 (7): 4215–4224.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal